JAMA Dermatology Study Highlights A study by Kathie P. Huang, M.D., of Brigham and Women’s Hospital, Boston, and colleagues examined the prevalence of comorbid (co-existing) conditions among patients with alopecia areata (AA), an autoimmune disease that presents with nonscarring hair loss from some or all hair-bearing areas of the body, typically the scalp…
Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy might be minimized if these treatments are given late in the day…
Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited…
1. Older, Sicker Men Unlikely to Benefit from Aggressive Therapy for Newly Diagnosed Prostate Cancer Older men with localized prostate cancer and other serious health conditions may not benefit from aggressive treatment for their cancer…
Skin cancer remains the most common cancer in the U.S., and as summer is quickly approaching, Americans are encouraged to take a few simple steps to protect their health and prevent skin cancer throughout this upcoming season. The U.S…
JAMA Dermatology Study Highlights A research letter by Kamal Jethwani, M.D., M.P.H., of the Center for Connected Health, Boston, and colleagues suggests that clinicians can learn about the perceptions and misconceptions of diseases like acne via Twitter, and communicate reliable medical information on the popular social media platform…
JAMA Dermatology Study Highlights A study by Chrysalyne D. Schmults, M.D., M.S.C.E., of Brigham and Women’s Hospital, Boston, and colleagues suggests cutaneous squamous cell carcinoma (CSCC) carries a low but significant risk of metastasis and death. The ten-year retrospective cohort study was conducted at an academic medical center in Boston, and included 985 patients with 1,832 tumors…
Clinically and Statistically Significant Reduction of Chronic Pruritus (Itch) Seen in Psoriasis Patients Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), has announced headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients…
Sunless tanning - whether with lotions, bronzers or tanning pills - has been promoted as an effective substitute to dodge the health risks of ultraviolet rays, but if the products don’t provide the perfect tan, young women likely will not use them, according to a Baylor University researcher. “The feeling is ‘I tan, I feel good, I’ll look good tomorrow . . . What’s health?’” said Jay Yoo, Ph.D…
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found…